Dr. Sriram H. Balasubramanian, MD

Dr. Balasubramanian practices at Bala Family Practice in Bel Air, Maryland.

Dr. Balasubramanian's NPI, 1952366056, was assigned on April 20, 2006. Dr. Balasubramanian holds Maryland license D0052279.

Dr. Balasubramanian's primary practice is Bala Family Practice, at 2021B Emmorton Rd, Bel Air, MD 21015 in Harford County. The practice phone is (410) 569-1001.

Dr. Balasubramanian's primary practice is Bala Family Practice in Bel Air, Maryland. Dr. Balasubramanian is also affiliated with University of Maryland Upper Chesapeake Medical Center Bel Air. The medical group on file is Bala Family Practice. Dmand AI also links Dr. Balasubramanian to 1 more hospital, 5 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balasubramanian practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Balasubramanian's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Balasubramanian is licensed in Maryland.

CMS data shows 46,954 Medicare services from Dr. Balasubramanian across 97 procedure codes in 2024, for 1,139 Medicare patients. Medicare paid $706,264 for them. Every service was in an office.

CMS counts 1,139 Medicare patients who saw Dr. Balasubramanian in 2024. The largest group is 65 to 74, with 523 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Balasubramanian's median patient age at 57, with 49% women.

In 2024, Dr. Balasubramanian wrote 15,851 Medicare Part D claims for 1,110 patients. 83% of them were for generic drugs. CMS names the drug for 14,840 of them, across 214 drugs with 11 or more claims each, at $2,704,055 in total drug cost. In 2023, CMS named 13,668 claims across 205 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 38 out of 100 for Dr. Balasubramanian for performance year 2024, reported individually. Dr. Balasubramanian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Balasubramanian as offering telehealth. CMS counts 230 procedures of removal of skin lesions by Dr. Balasubramanian, more than 80% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 242 general payments to Dr. Balasubramanian from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Amgen Inc. paid the most, $967.